Colgate-Palmolive (CL) to Release Earnings on Friday

Key Points

• Colgate-Palmolive will release its Q1 2026 results before the market opens on Friday, April 24; analysts expect EPS of $0.95 and revenue of $5.2083 billion, and the company will host an earnings call on Friday, May 1 at 8:30 AM ET.
• In the most recent quarter Colgate reported $0.95 EPS (vs. $0.91 expected) and $5.23 billion in revenue, up 5.8% year-over-year, and it raised the quarterly dividend to $0.53 (ex-dividend April 20, payable May 15), implying a 2.5% yield.
• Analysts have a consensus rating of "Moderate Buy" with an average target of $95.56, while insiders have been net sellers recently (184,683 shares sold in the last 90 days); the stock trades around a 31.9 P/E and a market cap near $67.1 billion.

Colgate-Palmolive (NYSE:CL - Get Free Report) is expected to be posting its Q1 2026 results before the market opens on Friday, April 24th. Analysts expect Colgate-Palmolive to post earnings of $0.95 per share and revenue of $5.2083 billion for the quarter. Interested persons can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Friday, May 1, 2026 at 8:30 AM ET.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the company posted $0.91 EPS. Colgate-Palmolive's revenue for the quarter was up 5.8% on a year-over-year basis. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Trading Up 0.1%

NYSE CL opened at $83.61 on Friday. Colgate-Palmolive has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The stock has a 50-day moving average of $90.16 and a 200-day moving average of $83.67. The firm has a market cap of $67.08 billion, a PE ratio of 31.91, a price-to-earnings-growth ratio of 4.15 and a beta of 0.34.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a $0.53 dividend. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's dividend payout ratio is presently 79.39%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CL. The Goldman Sachs Group reissued a "buy" rating and issued a $100.00 target price on shares of Colgate-Palmolive in a research note on Friday, February 20th. JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $93.00 to $97.00 and gave the company an "overweight" rating in a research note on Monday, February 2nd. Royal Bank Of Canada set a $102.00 target price on Colgate-Palmolive in a research note on Thursday, April 9th. Barclays lowered their target price on Colgate-Palmolive from $88.00 to $79.00 and set an "equal weight" rating for the company in a research note on Tuesday. Finally, Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Sunday, March 29th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $95.56.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the company's stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares of the company's stock, valued at $1,306,757.53. This represents a 53.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider John Hazlin sold 20,989 shares of the company's stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider directly owned 17,645 shares of the company's stock, valued at $1,663,041.25. The trade was a 54.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 184,683 shares of company stock worth $17,486,693. 0.43% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Schnieders Capital Management LLC. grew its holdings in shares of Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company's stock worth $1,136,000 after acquiring an additional 245 shares during the period. Brighton Jones LLC grew its holdings in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after acquiring an additional 450 shares during the period. Quantitative Investment Management LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $286,000. 71 West Capital Partners purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $254,000. Finally, Zions Bancorporation National Association UT grew its holdings in shares of Colgate-Palmolive by 949.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 3,179 shares of the company's stock worth $251,000 after acquiring an additional 2,876 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.